Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.4 DKK | +1.07% | +0.27% | -15.19% |
Mar. 13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
Mar. 13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.19% | 1.66B | |
+25.83% | 661B | |
+26.76% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.75% | 231B | |
+5.27% | 200B | |
-8.75% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BAVA Stock
- News Bavarian Nordic A/S
- Bavarian Nordic Receives Accelerated Assessment Status for Chikungunya Vaccine